Search Results - (Author, Cooperation:K. Gelmon)
-
1Latest Papers from Table of Contents or Articles in PressS. P. Shah ; A. Roth ; R. Goya ; A. Oloumi ; G. Ha ; Y. Zhao ; G. Turashvili ; J. Ding ; K. Tse ; G. Haffari ; A. Bashashati ; L. M. Prentice ; J. Khattra ; A. Burleigh ; D. Yap ; V. Bernard ; A. McPherson ; K. Shumansky ; A. Crisan ; R. Giuliany ; A. Heravi-Moussavi ; J. Rosner ; D. Lai ; I. Birol ; R. Varhol ; A. Tam ; N. Dhalla ; T. Zeng ; K. Ma ; S. K. Chan ; M. Griffith ; A. Moradian ; S. W. Cheng ; G. B. Morin ; P. Watson ; K. Gelmon ; S. Chia ; S. F. Chin ; C. Curtis ; O. M. Rueda ; P. D. Pharoah ; S. Damaraju ; J. Mackey ; K. Hoon ; T. Harkins ; V. Tadigotla ; M. Sigaroudinia ; P. Gascard ; T. Tlsty ; J. F. Costello ; I. M. Meyer ; C. J. Eaves ; W. W. Wasserman ; S. Jones ; D. Huntsman ; M. Hirst ; C. Caldas ; M. A. Marra ; S. Aparicio
Nature Publishing Group (NPG)
Published 2012Staff ViewPublication Date: 2012-04-13Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Alleles ; Breast Neoplasms/diagnosis/*genetics/*pathology ; Clone Cells/metabolism/pathology ; DNA Copy Number Variations/genetics ; DNA Mutational Analysis ; Disease Progression ; *Evolution, Molecular ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic/genetics ; Genotype ; High-Throughput Nucleotide Sequencing ; Humans ; INDEL Mutation/genetics ; Mutation/*genetics ; Point Mutation/genetics ; Precision Medicine ; Reproducibility of Results ; Sequence Analysis, RNAPublished by: -
2Latest Papers from Table of Contents or Articles in PressP. Eirew ; A. Steif ; J. Khattra ; G. Ha ; D. Yap ; H. Farahani ; K. Gelmon ; S. Chia ; C. Mar ; A. Wan ; E. Laks ; J. Biele ; K. Shumansky ; J. Rosner ; A. McPherson ; C. Nielsen ; A. J. Roth ; C. Lefebvre ; A. Bashashati ; C. de Souza ; C. Siu ; R. Aniba ; J. Brimhall ; A. Oloumi ; T. Osako ; A. Bruna ; J. L. Sandoval ; T. Algara ; W. Greenwood ; K. Leung ; H. Cheng ; H. Xue ; Y. Wang ; D. Lin ; A. J. Mungall ; R. Moore ; Y. Zhao ; J. Lorette ; L. Nguyen ; D. Huntsman ; C. J. Eaves ; C. Hansen ; M. A. Marra ; C. Caldas ; S. P. Shah ; S. Aparicio
Nature Publishing Group (NPG)
Published 2014Staff ViewPublication Date: 2014-12-04Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Animals ; Breast Neoplasms/*genetics/*pathology/secondary ; Clone Cells/*metabolism/*pathology ; DNA Mutational Analysis ; Genome, Human/*genetics ; Genomics ; Genotype ; High-Throughput Nucleotide Sequencing ; Humans ; Mice ; Neoplasm Transplantation ; *Single-Cell Analysis ; Time Factors ; Transplantation, Heterologous ; *Xenograft Model Antitumor Assays/methodsPublished by: -
3Latest Papers from Table of Contents or Articles in PressDrögemöller, B. I., Brooks, B., Critchley, C., Monzon, J. G., Wright, G. E. B., Liu, G., Renouf, D. J., Kollmannsberger, C. K., Bedard, P. L., Hayden, M. R., Gelmon, K. A., Carleton, B. C., Ross, C. J. D.
The American Association for Cancer Research (AACR)
Published 2018Staff ViewPublication Date: 2018-04-14Publisher: The American Association for Cancer Research (AACR)Print ISSN: 1078-0432Electronic ISSN: 1557-3265Topics: MedicinePublished by: -
4Articles: DFG German National LicensesGelmon, K. A. ; Tolcher, A. ; O'Reilly, S. ; Campbell, C. ; Bryce, C. ; Shenkier, T. ; Ragaz, J. ; Ayers, D. ; Nakashima, L. ; Rielly, S. ; Dulude, H.
Springer
Published 1998Staff ViewISSN: 1569-8041Keywords: metastatic breast cancer ; paclitaxel ; schedulingSource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Abstract Background: Single-agent bi-weekly paclitaxel was studied as first-line metastatic treatment for breast cancer in a phase I–II trial. Patients and methods: Thirty-eight women with metastatic breast cancer were enrolled. Thirty-seven are evaluable for toxicity, 35 for response. Results: The MTD was defined at 160 mg/m2 q two weeks with dose limiting toxicity in two patients consisting of hematological toxicity (1) and neurotoxicity (2). Twenty patients were treated at 150 mg/m2, the recommended dose. Response rates were two CRs and nine PRs (overall 61%) at the RD of 150 mg/m2 and three CRs and 11 PRs for an overall RR of 67% for the two top doses. Conclusions: The good drug tolerance, response rates, and convenience over weekly treatment suggest this may be a worthwhile regimen.Type of Medium: Electronic ResourceURL: